Your browser doesn't support javascript.
loading
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Norsworthy, Kelly J; Gao, Xin; Ko, Chia-Wen; Pulte, E Dianne; Zhou, Jiaxi; Gong, Yutao; Shen, Yuan Li; Vallejo, Jonathon; Gwise, Thomas E; Sridhara, Rajeshwari; Deisseroth, Albert B; Farrell, Ann T; de Claro, R Angelo; Blumenthal, Gideon M; Pazdur, Richard.
Afiliação
  • Norsworthy KJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Gao X; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Ko CW; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Pulte ED; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Zhou J; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Gong Y; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Shen YL; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Vallejo J; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Gwise TE; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Sridhara R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
  • Deisseroth AB; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Farrell AT; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • de Claro RA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Blumenthal GM; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
  • Pazdur R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD.
J Clin Oncol ; 40(8): 847-854, 2022 03 10.
Article em En | MEDLINE | ID: mdl-34890212

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Moldávia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Moldávia